使Ezetimibe:

Ruba S Darweesh1, Farah S Al-Qawasmi1, Mai S Khanfar1

  • 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

概括

埃泽胺固体脂质纳米颗粒 (SLN) 是为了提高溶解性和生物可用性而开发的. 优化的EZT-SLNs显示,与纯粹的ezetimibe相比,在体外释放和体内吸收增强.